Advances in oligonucleotide drug delivery
TC Roberts, R Langer, MJA Wood - Nature reviews Drug discovery, 2020 - nature.com
Oligonucleotides can be used to modulate gene expression via a range of processes
including RNAi, target degradation by RNase H-mediated cleavage, splicing modulation …
including RNAi, target degradation by RNase H-mediated cleavage, splicing modulation …
siRNA versus miRNA as therapeutics for gene silencing
JKW Lam, MYT Chow, Y Zhang, SWS Leung - Molecular Therapy-Nucleic …, 2015 - cell.com
Discovered a little over two decades ago, small interfering RNAs (siRNAs) and microRNAs
(miRNAs) are noncoding RNAs with important roles in gene regulation. They have recently …
(miRNAs) are noncoding RNAs with important roles in gene regulation. They have recently …
RNA interference technology in crop protection against arthropod pests, pathogens and nematodes
Scientists have made significant progress in understanding and unraveling several aspects
of double‐stranded RNA (dsRNA)‐mediated gene silencing during the last two decades …
of double‐stranded RNA (dsRNA)‐mediated gene silencing during the last two decades …
[HTML][HTML] RNA-based technologies for insect control in plant production
S Liu, M Jaouannet, DMA Dempsey, J Imani… - Biotechnology …, 2020 - Elsevier
RNA interference (RNAi) is a biological process in which small RNA (sRNA) molecules
sequence-specifically silence gene expression at the transcriptional or post-transcriptional …
sequence-specifically silence gene expression at the transcriptional or post-transcriptional …
Off-target effects of RNAi correlate with the mismatch rate between dsRNA and non-target mRNA
RNAi is a potent technique for the knockdown of target genes. However, its potential off-
target effects limit the widespread applications in both reverse genetic analysis and genetic …
target effects limit the widespread applications in both reverse genetic analysis and genetic …
Molecular mechanisms and potential therapeutical targets in Huntington's disease
C Zuccato, M Valenza, E Cattaneo - Physiological reviews, 2010 - journals.physiology.org
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG repeat
expansion in the gene encoding for huntingtin protein. A lot has been learned about this …
expansion in the gene encoding for huntingtin protein. A lot has been learned about this …
Antisense oligonucleotide therapies: the promise and the challenges from a toxicologic pathologist's perspective
KS Frazier - Toxicologic pathology, 2015 - journals.sagepub.com
Many antisense oligonucleotides (ASOs) from several classes of molecules are currently in
drug development. Despite over 20 years of pharmaceutical research, few ASOs have been …
drug development. Despite over 20 years of pharmaceutical research, few ASOs have been …
The promises and pitfalls of RNA-interference-based therapeutics
D Castanotto, JJ Rossi - Nature, 2009 - nature.com
The discovery that gene expression can be controlled by the Watson–Crick base-pairing of
small RNAs with messenger RNAs containing complementary sequence—a process known …
small RNAs with messenger RNAs containing complementary sequence—a process known …
Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity
AL Jackson, J Burchard, J Schelter, BN Chau, M Cleary… - Rna, 2006 - rnajournal.cshlp.org
Transfected siRNAs and miRNAs regulate numerous transcripts that have only limited
complementarity to the active strand of the RNA duplex. This process reflects natural target …
complementarity to the active strand of the RNA duplex. This process reflects natural target …
p53 activation by knockdown technologies
ME Robu, JD Larson, A Nasevicius, S Beiraghi… - PLoS …, 2007 - journals.plos.org
Morpholino phosphorodiamidate antisense oligonucleotides (MOs) and short interfering
RNAs (siRNAs) are commonly used platforms to study gene function by sequence-specific …
RNAs (siRNAs) are commonly used platforms to study gene function by sequence-specific …